Home> Products> improving glycemic control

{ "products": [ { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68822dd35b399ba6097ed11b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G 0.5 FORTE", "description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2151, "imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png", "tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-24T12:57:55.385Z", "updatedon": "2025-07-24T12:57:55.385Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "glimepiride and metformin hydrochloride tablets", "category": "DIABETIC RANGE", "tags": [ "glimepiride and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6842b8014256f7114dfbd884", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "Trelagliptin 100mg in TRELAQWK 100 is an innovative once-weekly oral medication formulated with Trelagliptin 100mg, specifically designed to support adults in managing type 2 diabetes mellitus (T2DM). As a member of the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class, it provides a simplified and effective approach to improving glycemic control when combined with a healthy diet and regular exercise. Its weekly dosing schedule enhances treatment adherence, offering a more sustainable option for long-term diabetes care.\n\nActive Ingredient:\nTrelagliptin 100mg\nA potent, long-acting DPP-4 inhibitor that helps maintain stable blood glucose levels by preserving incretin activity. Incretins are natural hormones that promote insulin release and suppress glucagon, playing a vital role in blood sugar regulation.\n\nCore Benefits:\nConvenient once-weekly dosing enhances patient compliance\n\nEffectively lowers both fasting and postprandial (after-meal) blood sugar\n\nPromotes natural insulin production without contributing to weight gain\n\nCarries a low risk of hypoglycemia, especially when not used with insulin\n\nCan be used alone or in combination with other antidiabetic medications like metformin or sulfonylureas\n\nMechanism of Action:\nTRELAQWK 100 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These hormones play a crucial role in regulating blood sugar after meals. By prolonging their activity, Trelagliptin enhances insulin secretion and reduces glucagon levels, resulting in improved glycemic control. Its extended half-life allows for once-a-week administration, setting it apart from daily DPP-4 inhibitors.\n\nDosage & Administration:\nRecommended Dose: One tablet per week, or as advised by your doctor\n\nHow to Take: With or without food, preferably on the same day each week\n\nIf a dose is missed, do not double the next dose; seek guidance from your healthcare provider\n\nPossible Side Effects:\nTRELAQWK 100 is generally safe and well-tolerated. Some individuals may experience:\n\nHeadache\n\nNasopharyngitis (mild cold symptoms)\n\nConstipation\n\nUpper respiratory tract infections\n\nRare allergic reactions such as rashes or skin irritation\n\nSeek immediate medical advice if you experience unusual symptoms such as severe abdominal pain, persistent skin reactions, or signs of pancreatitis.", "price": 3.0, "discountamount": 1.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medical advice", "generally safe", "healthcare provider", "food preferably", "extended halflife", "crucial role", "dpp4 enzyme", "sulfonylureas mechanism", "antidiabetic medications", "low risk", "vital role", "sustainable option", "regular exercise", "healthy diet", "effective approach", "support adults", "trelaqwk 100trelaqwk 100", "hormones play", "natural hormones", "dose seek guidance", "promote insulin release", "degrades incretin hormones", "experience unusual symptoms", "skin irritation seek", "onceaweek administration setting", "improved glycemic control", "regulating blood sugar", "weight gain carries", "suppress glucagon playing", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2132, "imageuri": "https://productimages.withfloats.com/actual/6842b80c8a53ae8db15a02ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/6842b80c8a53ae8db15a02ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-06T09:42:25.371Z", "updatedon": "2025-06-11T11:17:09.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2132", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trelagliptin 100mg", "category": "DIABETIC RANGE", "tags": [ "Trelagliptin side effects", "Trelagliptin brand name", "Trelagliptin brands in India", "Trelagliptin uses", "Trelagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 40", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 120.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-05-01T10:29:29.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide 40 mg", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6810aa8d5a26e4010ea41a99", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH MET", "description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "unusual tiredness", "medical advice", "monotherapy directions", "healthcare provider", "healthy diet", "chew continue", "meals swallow", "fat tissues", "dual mechanism", "hypoglycemia compared", "cardiovascular complications", "secondline treatment", "metformin dehydration", "insulin allowing", "bodys sensitivity", "kidneys reducing", "low risk", "diet exercise", "improving insulin sensitivity", "promoting glucose excretion", "reducing glucose production", "side effects risk", "biguanide class medication", "lowers blood glucose", "low blood pressure", "regular exercise routine", "metformin hydrochloride designed", "urinary tract infections", "dry mouth nausea", "blocking sglt2 proteins" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2093, "imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png", "tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-29T10:31:41.504Z", "updatedon": "2025-04-29T10:32:46.171Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-met/2093", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (12.5mg) ,Metformin Hydrochloride (500mg)", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin 12.5 mg+metformin 1000 mg", "empagliflozin 12.5mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2025-03-17T11:04:23.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35850f802c8856080561d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (25mg)", "description": "GLIEMPAFLOZIN 25 is an oral anti-diabetic medication used to manage Type 2 diabetes mellitus by helping control blood sugar levels. It belongs to the SGLT2 inhibitors (Sodium-Glucose Co-Transporter-2 inhibitors) class, which works by promoting glucose excretion through urine. This helps in lowering blood glucose levels and improving glycemic control in diabetic patients. Additionally, it may reduce the risk of cardiovascular complications in individuals with diabetes.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps in reducing high blood sugar levels in Type 2 diabetes mellitus patients.\nPromotes Weight Loss – Encourages calorie loss through glucose excretion, which may aid in weight management.\nCardiovascular Protection – Studies suggest it may help reduce the risk of heart failure and cardiovascular diseases in diabetic patients.\nSupports Kidney Health – Can help slow down the progression of diabetic kidney disease.\nReduces Blood Pressure – Helps in lowering blood pressure, especially in diabetic individuals with hypertension.\nLowers Risk of Hypoglycemia – Since it works independently of insulin, the risk of dangerously low blood sugar levels is minimized.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN 25 works by blocking the SGLT2 protein in the kidneys, which is responsible for glucose reabsorption. By inhibiting this protein, the medication promotes the excretion of excess glucose through urine, reducing blood sugar levels. This mechanism also leads to a mild diuretic effect, which may help in lowering blood pressure and aiding weight loss.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the tablet whole with water, with or without food.\nFollow a balanced diet and exercise routine to enhance effectiveness.\nRegularly monitor blood sugar levels as per your doctor’s advice.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN 25 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nIncreased urination\nUrinary tract infections (UTIs)\n Genital infections (e.g., yeast infections)\nDehydration or dizziness\nLow blood pressure\nIncreased thirst\nKetoacidosis (rare but serious)\nIf you experience severe allergic reactions, persistent infections, or unusual symptoms, consult your healthcare provider immediately.", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliempaflozin 25", "tablet daily", "sglt2 protein", "works independently", "diabetic individuals", "generally welltolerated", "exercise routine", "balanced diet", "food follow", "cardiovascular diseases", "heart failure", "cardiovascular complications", "empagliflozin 25mggliempaflozin 25", "excess glucose", "glucose reabsorption", "glucose excretion", "experience mild", "medication promotes", "promoting glucose excretion", "hypertension lowers risk", "mild diuretic effect", "diabetic patients additionally", "oral antidiabetic medication", "healthcare provider immediately", "unusual symptoms consult", "yeast infections dehydration", "moderate side effects", "healthcare provider swallow", "lowering blood pressure", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2044, "imageuri": "https://productimages.withfloats.com/actual/67a35882b85688fc926014d2.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35882b85688fc926014d2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:23:44.164Z", "updatedon": "2025-03-17T11:07:38.155Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-/2044", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 25 ", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg price in India", "Empagliflozin 25 mg uses", "Empagliflozin 25 mg substitute", "Empagliflozin dose 25 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "674b0a7ee34075b8291b14f1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets", "description": "Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.\n\n \nKey Benefits:\nEffective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.\nReduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.\nMinimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.\nImproves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.\nSustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.\nComprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.\nHow Does It Work?\nGlimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.\nVoglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.\nMetformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.\nTogether, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.\n\nDirections for Use:\nDosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.\nSwallow Whole: Do not crush or chew the tablet; it is designed for sustained release.\nTiming: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.\nFollow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.\nAlways consult your doctor before starting or adjusting your dosage.\n\nSide Effects:\nWhile Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nStomach discomfort or flatulence\nMild hypoglycemia (low blood sugar levels)\nRare but Serious Side Effects:\n\nSevere hypoglycemia\nLactic acidosis (from Metformin)\nAllergic reactions such as rash or itching\n\n", "price": 153.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "prescribed dosage", "ingredients address", "glycemic control", "targets fasting", "generally welltolerated", "glimiteris trio 0502500", "optimal results", "meals swallow", "healthcare professional", "holistic solution", "multifaceted nature", "cardiovascular issues", "neuropathy retinopathy", "insulin improving", "bodys response", "multiple pathways", "synergistic combination", "multifaceted approach", "dosage side effects", "delaying glucose absorption", "postprandial blood glucose", "metformin allergic reactions", "diarrhea stomach discomfort", "experience side effects", "reduce gastrointestinal discomfort", "work glimepiride stimulates", "proven antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2016, "imageuri": "https://productimages.withfloats.com/actual/674b0a80ec7bb8b7dcae8a8a.png", "tileimageuri": "https://productimages.withfloats.com/tile/674b0a80ec7bb8b7dcae8a8a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-11-30T12:52:14.799Z", "updatedon": "2024-11-30T12:52:14.799Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-0-5-mg-voglibose-0-2-mg-metformin-hydrochloride-sr-500-mg-tablets/2016", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS TRIO 0.5/0.2/500 ", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122bef263d0316fb4c9dcb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gliclazide IP (40 mg) , Pioglitazone Hydrochloride IP (15 mg) , Metformin Hydrochloride IP (500 mg)", "description": "TRI-GLICLAGLAZE 40 is a powerful oral anti-diabetic medication formulated to manage Type 2 Diabetes Mellitus effectively. This combination of three potent drugs—Gliclazide, Pioglitazone, and Metformin—works synergistically to control high blood sugar levels, improve insulin sensitivity, and help patients achieve better glycemic control. TRI-GLICLAGLAZE 40 is designed for patients who struggle to manage blood glucose levels with single medications or lifestyle changes alone. It is a comprehensive solution for long-term diabetes management and reducing the risk of complications related to uncontrolled blood sugar.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: TRI-GLICLAGLAZE 40 helps maintain optimal blood glucose levels by targeting different aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and reducing glucose production.\nReduces Insulin Resistance: Pioglitazone and Metformin work together to lower insulin resistance, making it easier for the body to use insulin effectively.\nImproves Long-Term Glycemic Control: By combining three active ingredients, this medication is particularly beneficial for those struggling with glycemic control through diet or monotherapy alone.\nReduces Risk of Diabetes Complications: Controlling blood sugar levels helps prevent diabetes-related complications such as nerve damage, kidney disease, and cardiovascular problems.\nSupports Weight Management: Metformin, in particular, has been known to assist with weight management, which is important for patients with Type 2 Diabetes.\n \n\nHow Does It Work?\n \nTRI-GLICLAGLAZE 40 works through a multi-faceted mechanism to lower blood glucose levels:\n\nGliclazide stimulates the beta cells in the pancreas to release more insulin, which lowers blood sugar levels post-meal.\n\nPioglitazone enhances the body's sensitivity to insulin by promoting glucose uptake in the muscle and fat cells while also decreasing glucose production in the liver.\n\nMetformin reduces the production of glucose in the liver and improves insulin sensitivity. It also decreases the absorption of sugar from the intestines, ensuring better blood sugar control throughout the day.\n\nThis combination of ingredients targets multiple pathways involved in glucose regulation, making it an effective option for individuals with Type 2 Diabetes who require more comprehensive blood sugar control.\n\n \n\nDirections for Use:\n \nTake TRI-GLICLAGLAZE 40 exactly as prescribed by your doctor.\nUsually, it is taken once or twice daily with meals to minimize gastrointestinal discomfort.\nSwallow the tablet whole with water—do not crush or chew the tablet.\nContinue following your diet and exercise plan alongside the medication to achieve optimal blood sugar control.\nDo not skip doses, and consult your healthcare provider if you miss a dose.\n \n\nSide Effects:\n \nLike any medication, TRI-GLICLAGLAZE 40 may cause side effects, although not everyone experiences them. Some common and mild side effects include:\n\nHypoglycemia (Low Blood Sugar): Due to Gliclazide’s insulin-stimulating properties, low blood sugar may occur, especially if meals are skipped or exercise is excessive.\n\nGastrointestinal Issues: Metformin is known to cause digestive problems in some individuals, including nausea, vomiting, diarrhea, or stomach cramps.\n\nWeight Gain: Pioglitazone may cause weight gain in some users due to increased fat storage.\n\nFluid Retention: Pioglitazone may lead to water retention, especially in patients with heart conditions, increasing the risk of heart failure.\n\nHeadache and dizziness: These may occur as the body adjusts to the medication, but they are generally mild and temporary.\n\nLactic Acidosis (rare): A serious but rare side effect of Metformin, this condition requires immediate medical attention and is characterized by muscle pain, breathing difficulties, and weakness.\n\n ", "price": 145.0, "discountamount": 43.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "fat cells", "beta cells", "muscle pain", "fat storage", "Weight Gain", "nerve damage", "Key Benefits", "exercise plan", "Gliclazide IP", "heart failure", "stomach cramps", "kidney disease", "glucose uptake", "water retention", "insulin release", "Lactic Acidosis", "Fluid Retention", "Low Blood Sugar", "heart conditions", "rare side effect", "multiple pathways", "different aspects", "lifestyle changes", "Weight Management", "mild side effects", "Insulin Resistance", "digestive problems", "single medications", "glucose production", "glucose regulation", "three potent drugs", "insulin sensitivity", "healthcare provider", "breathing difficulties", "Diabetes Complications", "comprehensive solution", "Metformin Hydrochloride", "Gastrointestinal Issues", "multi-faceted mechanism", "cardiovascular problems", "high blood sugar levels", "Type 2 Diabetes Mellitus", "three active ingredients", "uncontrolled blood sugar", "Long-Term Glycemic Control", "gastrointestinal discomfort", "immediate medical attention", "optimal blood sugar control", "optimal blood glucose levels", "Pioglitazone Hydrochloride IP", "long-term diabetes management", "Effective Blood Sugar Control", "diabetes-related complications", "insulin-stimulating properties", "comprehensive blood sugar control", "powerful oral anti-diabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1994, "imageuri": "https://productimages.withfloats.com/actual/67122bf4ac30f07ce03345d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122bf4ac30f07ce03345d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:35:43.008Z", "updatedon": "2024-10-18T09:35:43.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-ip-40-mg-pioglitazone-hydrochloride-ip-15-mg-metformin-hydrochloride-ip-500-mg-/1994", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRI - GLICLAGLAZE 40 ", "category": "DIABETIC RANGE", "tags": [ "gliclazide+metformin hydrochloride tablets uses", "Gliclazide Metformin Pioglitazone brand name", "Gliclazide and Metformin hydrochloride tablets Use", "Gliclazide and Metformin Hydrochloride tablets pri", "Gliclazide and Metformin Hydrochloride Tablets bra", "Gliclazide 80 mg and Metformin Hydrochloride table", "", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }